Publications by authors named "Teruko Hino"

Claim this Profile
A
A randomized study of extended treatment with peginterferon alpha-2b plus ribavirin based on time to HCV RNA negative-status in patients with genotype 1b chronic hepatitis C.
Tatsuya Ide, Teruko Hino, Kei Ogata, Ichiro Miyajima, Reiichiro Kuwahara

Am J Gastroenterol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV.
Reiichiro Kuwahara, Ryukichi Kumashiro, Tatsuya Ide, Yuriko Koga, Teruko Hino

Dig Dis Sci· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A periappendiceal abscess during combination interferon and ribavirin treatment for chronic hepatitis C].
Teruko Hino, Tatsuya Ide, Takeshi Toubaru, Hiroko Korekoda, Hiroshi Kawano

Nihon Shokakibyo Gakkai Zasshi· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lamivudine treatment-related morphological changes of esophageal varices in patients with liver cirrhosis.
Hiroyuki Koga, Tatsuya Ide, Kazuhiko Oho, Reiichiro Kuwahara, Teruko Hino

Hepatol Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment with corticosteroid and lamivudine for autoimmune hepatitis in a patient with asymptomatic HBV infection.
Reiichiro Kuwahara, Hiroki Saitsu, Mitsuhiko Abe, Akio Takata, Kazuo Tanaka, Teruko Hino

Dig Dis Sci· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report.
Ryukichi Kumashiro, Yuriko Koga, Reiichirou Kuwahara, Tatsuya Ide, Teruko Hino

Hepatol Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment.
Tatsuya Ide, Ryukichi Kumashiro, Reiichiro Kuwahara, Hiroyuki Koga, Yuriko Koga, Teruko Hino

J Gastroenterol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe hepatotoxicity associated with a N-nitrosofenfluramine-containing weight-loss supplement: report of three cases.
Takumi Kawaguchi, Masaru Harada, Hidetoshi Arimatsu, Shuichiro Nagata, Yuriko Koga, Teruko Hino

J Gastroenterol Hepatol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting relapse after cessation of Lamivudine monotherapy for chronic hepatitis B virus infection.
Kiyoaki Ito, Yasuhito Tanaka, Etsuro Orito, Noboru Hirashima, Tatsuya Ide, Teruko Hino

Clin Infect Dis· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.
Reiichiro Kuwahara, Ryukichi Kumashiro, Hiroto Inoue, Ryo Tanabe, Eisuke Tanaka, Teruko Hino

Dig Dis Sci· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
Reiichiro Kuwahara, Ryukichi Kumashiro, Shiro Murashima, Kei Ogata, Kazuo Tanaka, Teruko Hino

J Med Virol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine.
Tatsuya Ide, Ryukichi Kumashiro, Yuriko Koga, Eisuke Tanaka, Teruko Hino

Am J Gastroenterol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of eicosapentaenoic acid therapy for ribavirin-related anemia in patients with chronic hepatitis C.
Tatsuya Ide, Takashi Okamura, Ryukichi Kumashiro, Yuriko Koga, Teruko Hino

Int J Mol Med· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.
Teruko Hino, Ryukichi Kumashiro, Tatsuya Ide, Yuriko Koga, Kunihide Ishii

Int J Mol Med· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of drug induced liver injury related pioglitazone].
Akiko Hisamochi, Ryukichi Kumashiro, Yuriko Koga, Eisuke Tanaka, Tatsuya Ide, Teruko Hino

Nihon Shokakibyo Gakkai Zasshi· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels.
Tatsuya Ide, Ryukichi Kumashiro, Teruko Hino, Shiro Murashima, Kei Ogata

Hepatol Res· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C.
Ryukichi Kumashiro, Tatsuya Ide, Masaru Sasaki, Shiro Murashima, Hiroshi Suzuki, Teruko Hino

Hepatol Res· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis